Beatson Institute For Cancer Research

Overview

Legal name

BEATSON INSTITUTE FOR CANCER RESEARCH

Region

Unknown

Registered address

GARSCUBE ESTATE

SWITCHBACK ROAD

BEARSDEN

GLASGOW

G61 1BD

Insolvency history

No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller Controls 1

1

Company Active PRIVATE-LIMITED-GUARANT-NSC

Beatson Institute For Cancer Research

CRN SC084170

2

Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Cancer Research UK

CRN 04325234

Company events

Reference milestones and recent Companies House filing stream events.

5 events

31 Dec

2026

Accounts due

Accounts Due

Next accounts due date

24 Dec

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

10 Dec

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar

2025

Accounts filed

Accounts

Last accounts made up date

03 Aug

1983

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2023

Funded years

2023

Age at first award

39 years

Projects

2023 Collaborative R&D

Project LIPICARE - Combining nanotechnology, gene editing and CAR-T to create a 'one-shot' cure for cancer

1 Feb 2023 to 31 Jan 2026

Awarded

£0

Total cost £0

LIPICARE is a bold and ambitious project conceived by a consortium of the UK's leading scientists in the field of gene and cancer therapy. We aim to combine advances in nanotechnology, cell therapy and gene editing to create a one-shot cure for cancer. Chimeric Antigen Receptor -- T cell (CAR-T) cancer immunotherapy involves genetically manipulating immun...

Product types

Collaborative R&D